Editorial: sorafenib toxicity, a biomarker of effect?

Aliment Pharmacol Ther. 2017 Jun;45(11):1469-1470. doi: 10.1111/apt.14033.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents
  • Benzenesulfonates
  • Biomarkers
  • Humans
  • Niacinamide* / analogs & derivatives
  • Phenylurea Compounds*
  • Pyridines
  • Sorafenib

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Biomarkers
  • Phenylurea Compounds
  • Pyridines
  • Niacinamide
  • Sorafenib